Neuroendocrine tumor treatment

  • US 9,006,224 B2
  • Filed: 11/20/2006
  • Issued: 04/14/2015
  • Est. Priority Date: 11/21/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating pancreatic neuroendocrine tumors, comprising administering to a human subject in need thereof a therapeutically effective amount of 40-O-(2-hydroxyethyl)-rapamycin as a monotherapy and wherein the tumors are advanced tumors after failure of cytotoxic chemotherapy.

View all claims
  • 1 Assignment
Timeline View
Assignment View